(Q36843397)

16 August 2017

Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study (English)

1 reference

16 August 2017

1 reference

1 reference

Hiroyuki Komatsu

1

1 reference

16 August 2017

Shouichi Fujimoto

2

1 reference

16 August 2017

Seiichiro Hara

3

1 reference

16 August 2017

Yuji Sato

4

1 reference

16 August 2017

Kazuhiro Yamada

5

1 reference

16 August 2017

Kazuo Kitamura

6

1 reference

16 August 2017

28 May 2008

1 reference

Clinical Journal of the American Society of Nephrology

16 August 2017

1 reference

16 August 2017

3

1 reference

16 August 2017

5

1 reference

16 August 2017

1301-1307

1 reference

The IgA nephropathy treatment dilemma

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Tubular lesions determine prognosis of IgA nephropathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

The commonest glomerulonephritis in the world: IgA nephropathy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Corticosteroids in IgA nephropathy: a randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

"Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

A tricontinental view of IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Regression of IgA nephropathy: a repeat biopsy study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

Tonsillectomy does not prevent a progressive course in IgA nephropathy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518790

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

5 September 2018

1 reference

12 December 2020

Treatment of IgA nephropathy

1 reference

12 December 2020

Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy

1 reference

12 December 2020

IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria

1 reference

12 December 2020

Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy

1 reference

12 December 2020

Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version

1 reference

12 December 2020

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.00310108

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18508946

1 reference